James Campbell
- Oncology top 2%
- PARP inhibition in cancer therapy 8
- Cancer-related Molecular Pathways 6
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 6
- Genomics and Chromatin Dynamics 5
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Biological Psychiatry top 10%
- Reproductive Medicine top 5%
-
- Advanced Proteomics Techniques and Applications 7
-
- Alzheimer's disease research and treatments 6
-
- Healthcare Policy and Management 5
James Campbell
59 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 139
- Oncology 1.2k
- Molecular Biology 2.1k
- Cancer Research 374
- Biological Psychiatry 60
- Reproductive Medicine 179
Countries citing papers authored by James Campbell
This map shows the geographic impact of James Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Campbell more than expected).
Fields of papers citing papers by James Campbell
This network shows the impact of papers produced by James Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Campbell. The network helps show where James Campbell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Campbell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2018 | 54 | |
| 3 | 2018 | 2 | |
| 4 | 2018 | 22 | |
| 5 | 2017 | 58 | |
| 6 | 2017 | 18 | |
| 7 | 2017 | 47 | |
| 8 | 2016 | 47 | |
| 9 | 2016 | 58 | |
| 10 | 2016 | 270 | |
| 11 | 2015 | 29 | |
| 12 | 2015 | 11 | |
| 13 | 2014 | 0 | |
| 14 | 2013 | 279 | |
| 15 | 2013 | 98 | |
| 16 | 2013 | 184 | |
| 17 | 2012 | 148 | |
| 18 | 2009 | 5 | |
| 19 | 2005 | 9 | |
| 20 | The Role of Tamoxifen in Premenopausal Women with Metastatic Carcinoma of the Breast - An Update | 1981 | 1 |
About James Campbell
James Campbell is a scholar working on Biological Psychiatry, Oncology and Molecular Biology, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Advanced Proteomics Techniques and Applications (7 papers), CRISPR and Genetic Engineering (6 papers), Cancer-related Molecular Pathways (6 papers), Alzheimer's disease research and treatments (6 papers), Cancer Genomics and Diagnostics (5 papers), Genomics and Chromatin Dynamics (5 papers) and Healthcare Policy and Management (5 papers). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (2.1k citations) and Cancer Research (374 citations). James Campbell has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Kerry Fenwick, Iwanka Kozarewa, Rachel Brough, Ioannis Assiotis, Lina Chen, Asha Konde, Florent Elefteriou and Julie A. Sterling. Their work appears in journals such as Molecular Cancer Therapeutics, The Journal of Pathology, PROTEOMICS, PLoS ONE and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.